Quick Answer
REVELATION BIOSCIENCES, INC. reported Research And Development Expense of $4.06 million for the year ending 2025.
- REVELATION BIOSCIENCES, INC. showed an increase of +14.5% in Research And Development Expense from 2024 to 2025.
- This data is from REVELATION BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $1.56 million | Q2 2021: $1.16 million | Q3 2021: $1.53 million | Q1 2022: $3.68 million | Q2 2022: $975.6 thousand | Q3 2022: $381.6 thousand | Q1 2023: $525.3 thousand | Q2 2023: $909.3 thousand | Q3 2023: $1.65 million | Q1 2024: $717.6 thousand | Q2 2024: $1.39 million | Q3 2024: $831.0 thousand | Q1 2025: $858.8 thousand | Q2 2025: $1.32 million | Q3 2025: $922.9 thousand.
- Over the full 5 years of available data (2021 to 2025), REVELATION BIOSCIENCES, INC.'s Research And Development Expense has declined by 41.2%.
- Historical annual values: Fiscal year 2025: $4.06 million | Fiscal year 2024: $3.55 million | Fiscal year 2023: $4.15 million | Fiscal year 2022: $5.38 million | Fiscal year 2021: $6.91 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: